Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  fatigue
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 68 for your search:
Start Over
Phase IV Study of Epoetin alfa in Women With Stage I, II, or III Breast Cancer and Chemotherapy-Related Anemia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0011004, ORTHO-PR-00-27-012, ORTHO-PR-01-27-003, NCI-G01-2002, NCT00022386
Management of Insomnia in Breast Cancer Patients
Phase: Phase III, Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: BRS0008, K07CA132916-01A1, 25740, NCT01011218
Phase III Prevalence Study of Paroxetine Hydrochloride for Fatigue in Cancer Patients Receiving Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: URCC-U1996, NCI-P97-0088
Phase III Randomized Study of Epoetin Alfa versus Placebo in Anemic Patients Receiving Chemotherapy for Stage IV Metastatic Breast Cancer (Summary Last Modified 02/1999)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18-80
Sponsor: NCI
Protocol IDs: RPCI-DS-97-10, ORTHO-PR-96-27-004, NCI-G98-1394
Methylphenidate in Treating Patients With Melanoma
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066161, E-2Z96, NCI-P98-0130, NCT00003266
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Over 17
Sponsor: NCI, Other
Protocol IDs: 99-102, MSKCC-99102, NCI-G00-1772, NCT00005805
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000069417, NCCTG-N01C9, NCI-P02-0226, N01C9, NCT00040885
Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069451, U10CA076001, CALGB-30102, NCT00042770
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069477, U10CA037420, URCC-U2901, NCI-5952, NCI-P02-0228, NCT00042848
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0122, CDR0000269100, NCT00053053
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000301881, ECOG-E1Z01, E1Z01, NCT00060398
Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCCWFU-98101, U10CA081851, CCCWFU-BGOI-152, NCT00066859
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: CCCWFU-97202, U10CA081851, WFU 97202, NCT00096356
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000349424, NCCTG-N01C5, N01C5, NCT00075842
Levocarnitine in Treating Fatigue in Cancer Patients
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000384087, ECOG-E4Z02, E4Z02, NCT00091169
Phase III Randomized Study of Donepezil Hydrochloride in Patients Who Have Undergone Partial- or Whole-Brain Irradiation for Brain Tumors
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCCWFU-91105, WFU 91105°, NCT00369785, WFU-91105
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N05C7, NCI-2012-02701, CDR0000495148, N05C7, NCT00376675
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000544841, U10CA037420, URCC-U1105, URCC-04-02, U1105, NCT00475085
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Closed
Age: Premenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000594003, IBCSG-24-02-ANZ0701, ANZ0701, CALGB-IBCSG-24-02-ANZ0701, IBCSG-ANZ0701, NCT00659373
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N07C2, NCI-2009-00872, CDR0000597665, N07C2, NCT00719563
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000617081, S0715, U10CA037429, SWOG-S0715, NCT00775645
Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: Adult
Sponsor: NCI, Other
Protocol IDs: MCC-11995, HM11995, CDR0000641994, NCI-2011-00234, MCV-MCC-11995, NCT00902330
Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: UCCO08106; URCC0701, U10CA037420, UCCO-08106, URCC 0701, URCC-O08106, NCT00924651
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1115, CDR0000727326, NCI-2012-00700, NCT01546987
Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000555830, P30CA006927, FCCC-FCRB-05-009, FCRB-05-009, NCT00509626
Start Over